Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer

Nat Commun. 2022 Feb 8;13(1):732. doi: 10.1038/s41467-022-28424-3.

Abstract

Broadly-neutralizing antibodies (bNAbs) against HIV-1 Env can protect from infection. We characterize Ab1303 and Ab1573, heterologously-neutralizing CD4-binding site (CD4bs) antibodies, isolated from sequentially-immunized macaques. Ab1303/Ab1573 binding is observed only when Env trimers are not constrained in the closed, prefusion conformation. Fab-Env cryo-EM structures show that both antibodies recognize the CD4bs on Env trimer with an 'occluded-open' conformation between closed, as targeted by bNAbs, and fully-open, as recognized by CD4. The occluded-open Env trimer conformation includes outwardly-rotated gp120 subunits, but unlike CD4-bound Envs, does not exhibit V1V2 displacement, 4-stranded gp120 bridging sheet, or co-receptor binding site exposure. Inter-protomer distances within trimers measured by double electron-electron resonance spectroscopy suggest an equilibrium between occluded-open and closed Env conformations, consistent with Ab1303/Ab1573 binding stabilizing an existing conformation. Studies of Ab1303/Ab1573 demonstrate that CD4bs neutralizing antibodies that bind open Env trimers can be raised by immunization, thereby informing immunogen design and antibody therapeutic efforts.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antibodies, Neutralizing / isolation & purification
  • Antibodies, Neutralizing / pharmacology*
  • Antibodies, Neutralizing / therapeutic use
  • Antibodies, Neutralizing / ultrastructure
  • Binding Sites
  • CD4 Antigens / immunology
  • CD4 Antigens / metabolism
  • Cryoelectron Microscopy
  • Crystallography, X-Ray
  • Drug Design
  • HIV Antibodies / isolation & purification
  • HIV Antibodies / pharmacology*
  • HIV Antibodies / therapeutic use
  • HIV Antibodies / ultrastructure
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1 / immunology*
  • Humans
  • Macaca
  • Molecular Docking Simulation
  • Protein Binding
  • Protein Domains
  • Protein Multimerization
  • env Gene Products, Human Immunodeficiency Virus / immunology
  • env Gene Products, Human Immunodeficiency Virus / metabolism

Substances

  • Antibodies, Neutralizing
  • CD4 Antigens
  • HIV Antibodies
  • env Gene Products, Human Immunodeficiency Virus